Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure

NCT00004828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

FED

Sponsor class

Conditions

Tricuspid Atresia
Heart Defects, Congenital

Interventions

DRUG: liothyronine I 131

Sponsor

FDA Office of Orphan Products Development

Collaborators

[object Object]